Barbara Klencke
2018
In 2018, Barbara Klencke earned a total compensation of $969K as Chief Development Officer at ProNAi Therapeutics, a 44% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $185,200 |
|---|---|
| Option Awards | $318,060 |
| Salary | $463,000 |
| Other | $2,750 |
| Total | $969,010 |
Klencke received $463K in salary, accounting for 48% of the total pay in 2018.
Klencke also received $185.2K in non-equity incentive plan, $318.1K in option awards and $2.8K in other compensation.
Rankings
In 2018, Barbara Klencke's compensation ranked 9,349th out of 14,244 executives tracked by ExecPay. In other words, Klencke earned more than 34.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,349 out of 14,244 | 34th |
Division Manufacturing | 3,744 out of 5,765 | 35th |
Major group Chemicals And Allied Products | 1,408 out of 2,128 | 34th |
Industry group Drugs | 1,185 out of 1,817 | 35th |
Industry Pharmaceutical Preparations | 915 out of 1,391 | 34th |
Source: SEC filing on December 18, 2019.
Klencke's colleagues
We found two more compensation records of executives who worked with Barbara Klencke at ProNAi Therapeutics in 2018.